SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological ...

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced a strategic transaction to exclusively ...

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of ...

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® ...

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial unveiling of ...

NanoString Technologies, Inc., has announced the availability of the nCounter® Rat miRNA Expression Assay Kit for use on its nCounter Analysis System. “We are pleased to offer these researchers a ...

Personalized medicine has beomce a paradigm in lung cancer management; ~ 25–30% of advanced lung cancer patients could benefit from a targeted therapy. Several guidelines currently endorse routine ...

Another key benefit of using the NanoString nCounter technology is the low input requirements of the system: 1-5 ng RNA and 5-300 ng DNA. The technology supports sample types such as total RNA, cell ...

NanoString Technologies, Inc. NSTG recently made significant strides in its translational research business. The company entered into CosMxSpatial Molecular Imager partnerships with three specialty ...

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced the commercial unveiling of the nCounter Pro Analysis System, the next ...